Publications by authors named "Masanobu Funamoto"

Claim this Profile
I
Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients.
Masako Ohno, Akiko Yamamoto, Ayumu Ono, Genta Miura, Masanobu Funamoto

Eur J Clin Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
Yorihide Okuda, Hideji Nakamura, Kenya Yoshida, Hirayuki Enomoto, Hirokazu Uyama, Masanobu Funamoto

Cancer Sci· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone augments endothelin-1-induced cardiac myocyte hypertrophy with the reinforcement of the JNK pathway.
Yuichi Oshima, Yasushi Fujio, Masanobu Funamoto, Shinji Negoro, Masahiro Izumi

FEBS Lett· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation.
Keita Kunisada, Eiroh Tone, Shinji Negoro, Yoshikazu Nakaoka, Yuichi Oshima, Masanobu Funamoto

Cardiovasc Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart.
Tomoaki Osugi, Yuichi Oshima, Yasushi Fujio, Masanobu Funamoto, Atsuko Yamashita

J Biol Chem· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis